| Product ID | 71800-901_19d5024a-b131-41c3-8cee-5e20564154aa | 
| NDC | 71800-901 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Sumatriptan and Naproxen Sodium | 
| Generic Name | Sumatriptan And Naproxen Sodium | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2020-12-09 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA202803 | 
| Labeler Name | Innovida Phamaceutique Corporation | 
| Substance Name | SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM | 
| Active Ingredient Strength | 85 mg/1; mg/1 | 
| Pharm Classes | Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 |